Page last updated: 2024-11-01

norfloxacin and Hemorrhagic Disorders

norfloxacin has been researched along with Hemorrhagic Disorders in 1 studies

Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.

Hemorrhagic Disorders: Spontaneous or near spontaneous bleeding caused by a defect in clotting mechanisms (BLOOD COAGULATION DISORDERS) or another abnormality causing a structural flaw in the blood vessels (HEMOSTATIC DISORDERS).

Research Excerpts

ExcerptRelevanceReference
"A 65-year-old woman developed haemorrhagic diathesis due to a profound thrombocytopenia (thrombocyte count: 1 x 10(9)/l) within one week after a 10-day course of norfloxacin (2 x 400 mg/day), prescribed for cystitis."7.69[Immune thrombocytopenia attributed to norfloxacin]. ( Vlasveld, LT; Wensing, JW, 1997)
"A 65-year-old woman developed haemorrhagic diathesis due to a profound thrombocytopenia (thrombocyte count: 1 x 10(9)/l) within one week after a 10-day course of norfloxacin (2 x 400 mg/day), prescribed for cystitis."3.69[Immune thrombocytopenia attributed to norfloxacin]. ( Vlasveld, LT; Wensing, JW, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wensing, JW1
Vlasveld, LT1

Other Studies

1 other study available for norfloxacin and Hemorrhagic Disorders

ArticleYear
[Immune thrombocytopenia attributed to norfloxacin].
    Nederlands tijdschrift voor geneeskunde, 1997, Aug-23, Volume: 141, Issue:34

    Topics: Aged; Anti-Infective Agents; Autoimmune Diseases; Cystitis; Female; Hemorrhagic Disorders; Humans; N

1997